By binding with IGF-1, IGF-2, and insulin, IGF-1R activates downstream pathways including phosphoinositide 3 kinase (PI3K)/AKT and Ras/extracellular signal-regulated protein kinase (ERK) pathways,1 two frequently activated pathways in colorectal cancer. This evidence concerns the gene IGF1R and colorectal cancer.